Potential Prognostic Value of FDG PET/CT-derived Intratumoral Metabolic Heterogeneity in Neuroblastoma.
作者信息
Tran Evelyn, Joe Bonnie N
出版信息
Radiol Imaging Cancer. 2022 Nov;4(6):e229022. doi: 10.1148/rycan.229022.
Abstract
摘要
相似文献
1
Potential Prognostic Value of FDG PET/CT-derived Intratumoral Metabolic Heterogeneity in Neuroblastoma.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）衍生的神经母细胞瘤瘤内代谢异质性的潜在预后价值
Radiol Imaging Cancer. 2022 Nov;4(6):e229022. doi: 10.1148/rycan.229022.
2
The prognostic value of F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients.预处理神经母细胞瘤患者 F-FDG PET/CT 肿瘤内代谢异质性的预后价值。
Cancer Imaging. 2022 Jul 5;22(1):32. doi: 10.1186/s40644-022-00472-4.
3
Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.代谢指标和骨髓摄取模式对儿童神经母细胞瘤患者术前 18F-FDG PET/CT 的预后价值。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):306-315. doi: 10.1007/s00259-017-3851-9. Epub 2017 Nov 7.
4
Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.治疗前氟代脱氧葡萄糖正电子发射断层扫描在儿童神经母细胞瘤中的预后价值
Eur J Radiol. 2015 Dec;84(12):2633-9. doi: 10.1016/j.ejrad.2015.09.027. Epub 2015 Oct 18.
5
The Diagnostic Value of F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients.F-FDG PET/CT 骨髓摄取模式对儿童神经母细胞瘤患者骨髓受累的诊断价值。
Contrast Media Mol Imaging. 2022 Jan 6;2022:7556315. doi: 10.1155/2022/7556315. eCollection 2022.
6
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.18F-FDG PET/CT 和 123I-间碘苄胍显像在高危神经母细胞瘤中的应用：诊断比较和生存分析。
J Nucl Med. 2011 Apr;52(4):519-25. doi: 10.2967/jnumed.110.083303. Epub 2011 Mar 18.
7
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）在成神经细胞瘤随访中的应用，该成神经细胞瘤已变为间碘苄胍（MIBG）阴性。
Pediatr Blood Cancer. 2008 Dec;51(6):828-31. doi: 10.1002/pbc.21594.
8
Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on F-FDG PET/CT for Patients with Colorectal Cancer.肿瘤内代谢异质性参数对结直肠癌患者 F-FDG PET/CT 的预后价值。
Contrast Media Mol Imaging. 2022 Jan 30;2022:2586245. doi: 10.1155/2022/2586245. eCollection 2022.
9
Benign differentiation of treated neuroblastoma as a cause of false positive by I-MIBG SPECT/CT. Usefulness of F-FDG PET/CT.经治疗的神经母细胞瘤良性分化导致I-MIBG SPECT/CT假阳性。F-FDG PET/CT的应用价值
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Nov-Dec;38(6):389-390. doi: 10.1016/j.remn.2019.03.001. Epub 2019 Apr 15.
10
Establishment and validation of a nomogram with intratumoral heterogeneity derived from F-FDG PET/CT for predicting individual conditional risk of 5-year recurrence before initial treatment of nasopharyngeal carcinoma.建立并验证了一种基于 F-FDG PET/CT 肿瘤内异质性的列线图，用于预测鼻咽癌初始治疗前 5 年个体复发的条件风险。
BMC Cancer. 2020 Jan 15;20(1):37. doi: 10.1186/s12885-020-6520-5.
引用本文的文献
1
The baseline F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma.先天性神经母细胞瘤患儿的基线F-FDG PET/CT影像特征。
BMC Med Imaging. 2025 Aug 14;25(1):330. doi: 10.1186/s12880-025-01863-2.
本文引用的文献
1
The prognostic value of F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients.预处理神经母细胞瘤患者 F-FDG PET/CT 肿瘤内代谢异质性的预后价值。
Cancer Imaging. 2022 Jul 5;22(1):32. doi: 10.1186/s40644-022-00472-4.
Zotero 插件